A rare case of acute promyelocytic leukemia with IRF2BP2-RARA fusion; and literature review

BACKGROUND: Acute promyelocytic leukemia (APL) is commonly characterized by the fusion of retinoic acid receptor alpha (RARA) with promyelocytic leukemia (PML). Most APL patients acquire long-term survival after treatment with all-trans retinoic acid (ATRA) or arsenic agents-based chemotherapy. CASE...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yiping, Xu, Fang, Hu, Hong, Wen, Jingjing, Su, Jing, Zhou, Qiaolin, Qu, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684484/
https://www.ncbi.nlm.nih.gov/pubmed/31447564
http://dx.doi.org/10.2147/OTT.S217622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684484/
https://www.ncbi.nlm.nih.gov/pubmed/31447564
http://dx.doi.org/10.2147/OTT.S217622

Ejemplares similares